N
Nykode Therapeutics AS (VACBF)
PNK – Real Time Price. Currency in USD
0.35
0.00 (0.00%)
At close: Sep 10, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
PNK – Real Time Price. Currency in USD
0.35
0.00 (0.00%)
At close: Sep 10, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $44.7M significantly exceed its total debt $1.8M, ensuring strong financial flexibility
Total current assets $48.1M exceed Total current liabilities $4.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.1), showcasing prudent financial management
Interest coverage ratio (-342.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$5.5M limits the company's ability to reinvest or pay down debt
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 7M | 13M | 8M | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | -2M | -2M |
| Operating Income | -52M | -59M | -45M | -29M | -28M |
| Net Income | -42M | -36M | -37M | -13M | -23M |
| EBITDA | -50M | -57M | -43M | -27M | -26M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | -75 | 1.0 |
| Next year | N/A | 100 | 5.5 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -65.71 | N/A | 42.47 | 5.5 |
| Y/Y | 999 | -880.9 | N/A | 19.55 | 5.3 |
| 3y average | -16.1 | 26.04 | 28.89 | -96.49 | 5.5 |
| 5y average | -42.6 | -76.93 | -83.68 | -908.42 | 1.0 |
| Weighted average score | 4.3 | ||||
DCF model data has not been calculated yet.
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 47.61 | 1.20 | 4.0 |
| Payout ratio | N/A | 27.45 | N/A |
| 5-year dividend growth rate | N/A | 4.94 | N/A |
| Years of dividend increase | 0.00 | 0.00 | 1.0 |
| Weighted average score | 2.5 | ||
Fair Value data has not been calculated yet.
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | N/A | N/A |
| Intangible assets | N/A | N/A |
| Switching costs | N/A | N/A |
| Network effect | N/A | N/A |
| Economies of scale | N/A | N/A |
| Weighted average score | 1.0 | |